Pfizer

Pfizer is drawing attention to how artificial intelligence is being used to match patients to clinical trials more quickly. AI tools can scan patient records and trial criteria far faster than manual screening, helping to address the long-standing problem that many trials struggle to enrol enough participants. The topic is part of a wider debate about AI's growing role in drug development and patient care.